Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

HL-A antigens and multiple sclerosis.
Subcutaneous IFN-β1a to treat relapsing-remitting multiple sclerosis.
The Antiaging Protein Klotho Enhances Oligodendrocyte Maturation and Myelination of the CNS.
Imaging robust microglial activation after lipopolysaccharide administration in humans with PET.
Therapeutic class review, Neurological - multiple sclerosis dalfampridine (Ampyra(TM))
Optimizing IFN Beta - 1B Dose (Optims)
UPDATE 1-Teva Pharmaceutical banks on thrice-weekly Copaxone
Mitoxantrone for multiple sclerosis.
Momenta Pharmaceuticals Announces FDA Approval of ANDA for Glatopa(TM) (glatiramer acetate injection), the First Substitutable Generic for COPAXONE(R) (glatiramer acetate injection) 20mg
Restoration of axon conduction and motor deficits by therapeutic treatment with glatiramer acetate.
Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study.
Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes.
Cost-effectiveness analysis of interferon beta-1b as treatment for patients with clinically isolated syndrome suggestive of multiple sclerosis in Spain.
Predictors for multiple sclerosis relapses after switching from natalizumab to fingolimod.
Differential roles of microglia and monocytes in the inflamed central nervous system.
The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group.
Spasticity improvement in patients with relapsing-remitting multiple sclerosis switching from interferon-β to glatiramer acetate: the Escala Study.
Integrated analysis of daclizumab HYP pharmacokinetics from three phase 1 studies
Race to Erase MS Forum and Expo
Sanofi MS drug nears green light after pass-the-parcel marathon
Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis.
Sphingosine and FTY720 are potent inhibitors of the transient receptor potential melastatin 7 (TRPM7) channels.
A genome-wide association study of brain lesion distribution in multiple sclerosis.
Antiinflammatory effects of orientin-2″-o-galactopyranoside on lipopolysaccharide-stimulated microglia.
Pharmacokinetic properties and metabolism of idebenone.

Pages